000 | 00988 a2200265 4500 | ||
---|---|---|---|
005 | 20250514162926.0 | ||
264 | 0 | _c20040106 | |
008 | 200401s 0 0 eng d | ||
022 | _a0190-9622 | ||
024 | 7 |
_a10.1016/s0190-9622(03)02161-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStashower, Mitchell E | |
245 | 0 | 0 |
_aPregnancy rates associated with isotretinoin (Accutane) and the FDA. _h[electronic resource] |
260 |
_bJournal of the American Academy of Dermatology _cDec 2003 |
||
300 |
_a1202-3 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aDermatologic Agents _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsotretinoin _xadverse effects |
650 | 0 | 4 |
_aPregnancy _xdrug effects |
650 | 0 | 4 | _aPregnancy, Unwanted |
773 | 0 |
_tJournal of the American Academy of Dermatology _gvol. 49 _gno. 6 _gp. 1202-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0190-9622(03)02161-3 _zAvailable from publisher's website |
999 |
_c14374497 _d14374497 |